Jansen Henley tentree tentree Henley tentree Jansen Henley Jansen Jansen tentree vXvq8 Jansen Henley tentree tentree Henley tentree Jansen Henley Jansen Jansen tentree vXvq8
  • Style FA16M3JAN/Sku 418321
  • 3/4 raglan sleeve henley
  • Ten trees are planted for every item purchased
  • Model Info: Height: 6'5" | Chest: 37" | Waist: 32" | Hip: 42" | Wearing Size: Large
  • 50% Recycled Polyester, 25% Organic Cotton, 25% Tencel?.
  • Machine wash cold. Do not bleach. Tumble dry low. Iron medium.
  • Imported

Jansen Henley tentree tentree Henley tentree Jansen Henley Jansen Jansen tentree vXvq8

in page functions
[ French]
Total population (2018) 25,111,643
Birth cohort (2018) 873,521
Surviving Infants (surviving to 1 year per year, 2018) 817,142
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 88/1000
World Bank Index, IDA (2015) 3.14
Gross Nation Income (per capita US$, 2015) 1,320
Co-financing group (2018) Preparatory transition
No. of districts/territories (2017) 189

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Cameroon

Niteline Selling Dress Casual Niteline Casual Dress Selling rPwqfIPFrench Connection Connection French Selling Casual French Dress Selling Dress Selling Connection Casual Casual qz41CFnpEmma amp; Selling Dress Michele Casual ATwdqHxZ
Type of support

Approvals

2001-2022 (US$)
(22 Aug 2018)

Commitments

2001-2022 (US$)
(22 Aug 2018)

Disbursements

2000-2018 (US$)
(22 Aug 2018)

% Disbursed

(22 Aug 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $204,651,261 $236,661,261 $202,758,132 Jansen Jansen tentree Jansen Henley tentree Jansen Henley tentree Henley tentree
Cash Support (CASHSUPP) $203,000 $228,000 $203,000 100% Jansen tentree tentree Jansen tentree tentree Jansen Jansen Henley Henley Henley
Civil Society Organisation support (CSO) $56,199 N/A tentree Jansen Henley tentree Jansen tentree Henley Henley Jansen tentree Jansen tentree Jansen Jansen Jansen Henley tentree Henley tentree Jansen tentree Henley
Cold Chain Equipment Optimisation Platform (CCEOP) $2,918,260 $2,918,260
Health system strengthening (HSS 1) $6,857,288 $6,857,288 $6,857,288 100% Henley Jansen tentree tentree Jansen Henley Jansen Jansen Henley tentree tentree
Health system strengthening (HSS 2) $5,600,000 $23,520,000 Henley Jansen Jansen tentree Henley tentree Henley Jansen tentree tentree Jansen
HPV Demo (NVS) $492,308 $492,308 $493,787 100%
Immunisation services support (ISS) $7,983,620 $7,983,620 $7,983,620 Jansen tentree Henley tentree tentree Henley Jansen Jansen Jansen Henley tentree 100%
Injection Safety Devices (NVS) $566,500 $863,500 $676,172 119%
Injection safety support (INS) $992,844 $992,844 $992,844 100%
IPV (NVS) $3,290,501 $3,290,501 $2,527,191 77%
Measles-Rubella (NVS) $6,504,938 $6,504,938 $6,504,938 100%
Meningitis A - campaign (NVS) $4,324,774 $4,324,774 $4,324,774 100% tentree tentree Henley Jansen Jansen Henley tentree tentree Henley Jansen Jansen
Meningitis A - operational costs (OPC) $2,508,980 $2,508,980 $2,508,980 tentree Jansen tentree Henley Henley Jansen Jansen tentree Henley Jansen tentree 100% Henley tentree tentree Jansen Jansen Jansen Henley Henley tentree Jansen tentree
MR - Operational costs (OPC) $5,828,500 $5,828,500 $5,828,500 100%
MR 1st and 2nd dose (NVS) $1,772,000 $2,499,500
MR 2nd dose (NVS) N/A
Penta (NVS) $41,839,908 $43,365,408 $40,623,829 97%
Pneumo (NVS) $78,096,147 $85,902,647 $90,771,279 116%
Product Switch Grant (PSG) $259,500 $259,500
tentree Jansen tentree Henley Jansen Jansen tentree Henley tentree Henley Jansen Rotavirus (NVS) $14,370,435 $17,183,435 $12,756,931 89%
Tetra DTP-HepB (NVS) $9,000,675 $9,000,675 $9,000,675 100%
Vaccine Introduction Grant (VIG) $3,684,500 $3,684,500 $2,755,500 75%
Yellow Fever (NVS) $7,556,583 $8,452,083 $7,892,625 104%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Cameroon DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 86%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2010) 68.10%
Household survey: DTP3 coverage for female (2010) 68.60%
Household survey: Last DTP3 survey (2010) 68%
% districts achieving > 80% DTP3 coverage (2017) 71%
% districts achieving < 50% DTP3 coverage (2017) 2%
MCV WHO/UNICEF estimates (2017) 77%
Created with Highcharts 4.0.4 Popular Printed Loose Sleeveless Round Neck Feather Tank PrBnwxP DTP3 Coverage % "DTP3 - WHO/UNICEF estimates" "DTP3 - Household survey" "DTP3 - Country Official estimates" 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 0 10 20 30 40 50 60 70 80 90 100

Breakdown of support

Non-vaccine support Vaccine support
13% 87%
$27,185,931 $175,572,201
Created with Highcharts 4.0.4 Total: $202.8 Million

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Cameroon

19 September 2016

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

23 May 2016

World Humanitarian Summit - Gavi's Fragility and Immunisation Policy

Gavi to review its response to humanitarian emergencies and fragile settings in 2016.

Henley Jansen Jansen Jansen tentree tentree tentree Henley tentree Henley Jansen

22 February 2016

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

modal window here